The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...

PharmStars is accepting applications for its eighth cohort since CEO Naomi Fried founded it four years ago, revolving around ...

The biotech industry in 2024 was marked by some contradictions: Even as layoffs continued to rip through companies large and ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

Welcome to a new edition of Spoonful of Technology, where we look at how technology can solve key pharma industry challenges.

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.

A three-step process underscores new clinical practice guidelines for primary and specialty care clinicians to evaluate ...

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...